Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H16N4O3.2Cl |
| Molecular Weight | 359.208 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 2 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].[Cl-].O\N=C\C1=CC=[N+](COC[N+]2=CC=C(C=C2)\C=N\O)C=C1
InChI
InChIKey=ZIFJVJZWVSPZLE-UHFFFAOYSA-N
InChI=1S/C14H14N4O3.2ClH/c19-15-9-13-1-5-17(6-2-13)11-21-12-18-7-3-14(4-8-18)10-16-20;;/h1-10H,11-12H2;2*1H
Obidoxime is an antidote for organophosphorous nerve agent poisoning including chlorosarin, cyclosarin (GF), R-33 (VR), R-VX, sarin (GB), tabun (GA), VX, chlorosoman, soman (GD), and organophosphorous pesticides. It acts as an acetylcholinesterase (AChE) reactivator. In combination with atropine obidoxime can be used to treat super toxic organophosphate poisoning by relieving the symptoms of skeletal neuromuscular blocking that occurs during a cholinergic crisis.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C66880
Created by
admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
7605
Created by
admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
|
PRIMARY | RxNorm | ||
|
114-90-9
Created by
admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
|
PRIMARY | |||
|
2138
Created by
admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
|
PRIMARY | |||
|
D009768
Created by
admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
|
PRIMARY | |||
|
8250
Created by
admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
|
PRIMARY | |||
|
3HXR312Z9M
Created by
admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
|
PRIMARY | |||
|
DTXSID70921258
Created by
admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
|
PRIMARY | |||
|
m8097
Created by
admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
|
PRIMARY | Merck Index | ||
|
100000083629
Created by
admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
|
PRIMARY | |||
|
CHEMBL451635
Created by
admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
|
PRIMARY | |||
|
C82265
Created by
admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
|
PRIMARY | |||
|
757237
Created by
admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
|
PRIMARY | |||
|
204-059-5
Created by
admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
|
PRIMARY | |||
|
SUB09394MIG
Created by
admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD
